⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Medincell: Publication of the 2026 Financial Calendar
businesswire.com
TEVA
Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
globenewswire.com
RPRX
TEVA
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
globenewswire.com
RPRX
TEVA
Parker Waichman LLP Files Lawsuit on behalf of Chicago Resident in the Paragard MDL Alleging Injuries Caused by Breakage of the Copper IUD
prnewswire.com
TEVA
Psoriasis Market to Exhibit Growth at a CAGR of 1.7% During the Forecast Period (2025-2034), Owing to Continuous Innovation in Biologic Therapies and Approval of Oral Small Molecules | DelveInsight
prnewswire.com
TAK
JNJ
CANF
AMGN
ABBV
NVS
BMY
AZN
BHC
LLY
UCB
LEO
REGN
XBI
IBB
JAZZ
MRK
SNY
GILD
INCY
PFE
LULU
PRTH
DRH
BIIB
TEVA
ARCT
HRMY
CRSP
NTLA
EDIT
SNOW
DDOG
CRM
GOOG
MSFT
AAPL
AMZN
TSLA
NVDA
META
NFLX
DIS
CMCSA
VZ
T
KO
PEP
MCD
SBUX
HD
EXAS
ILMN
BNTX
MRNA
XOM
CVX
BA
CAT
GE
IBM
INTC
CSCO
ADBE
QCOM
AMAT
MU
ORCL
ACN
COST
WMT
TGT
LOW
HON
GD
LMT
RTX
BAX
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
TEVA
Bleichmar Fonti & Auld LLP Announces New Partners
businesswire.com
TSLA
TEVA
GVA
TWST
BA
TD
PATH
CNC
ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis
prnewswire.com
TEVA
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
globenewswire.com
TEVA
WEIFX SECURITIES: Wildermuth Fund Investors with Losses are Reminded to Contact BFA Law by December 29 Securities Fraud Class Action Deadline Ready to Announce with Confidence?
newsfilecorp.com
ARE
BRBR
INSP
TSLA
TEVA